Lilly has launched six early-stage clinical programs, and 34 discovery programs with a focus on incretins, amylins, and novel ...

(Reuters) - Eli Lilly and Co said on Monday it started a late-stage trial testing whether one of its experimental COVID-19 antibody treatments can prevent the spread of infections in residents and ...

The Food and Drug Administration (FDA) announced Friday that it has issued emergency use authorization (EUA) for Eli Lilly's new monoclonal antibody treatment. Clinical trials have shown the treatment ...